Center for Addiction Medicine

News

Top-Ten Hospital MGH Is Rated #1 in Adult Psychiatry Again

MGH #1 in U.S. News & World Report annual Honor Roll of America’s Best Hospitals

Massachusetts General Hospital is ranked among the top hospitals in the U.S. News & World Report annual Honor Roll of America’s Best Hospitals for the 24th year in a row. Supporting that distinction are top-ten ratings in 16 different speciality areas, including Adult Psychiatry, which retained its #1 rating from last year.

Events for 2016’s National Recovery Month focus on raising awareness

National Recovery Month panel of events

This September, Massachusetts General Hospital, led by the Substance Use Disorders Initiative, will mark National Recovery Month by hosting a slate of educational events to raise awareness of prevention, treatment and recovery support services. The 2016 theme—Join the Voices for Recovery: Our Families, Our Stories, Our Recovery!—highlights the importance of families, communities, and individuals sharing…MORE

Needham Forum on Marijuana Legalization with Dr. John Kelly

The Needham Public Health Department, the Needham Interfaith Clergy Association, State Rep. Denise Garlick and the Needham Coalition for Youth Substance Abuse Prevention present “Marijuana Legalization, Why It Matters To You” on Thursday, September 22 at 7:00 PM at Needham Town Hall. The focus of the forum is to share the science and public health…MORE

Randi Schuster, Ph.D., of CAM is the winner of the 2016 Emerson Award

Randi Schuster talk

The 2016 Eugene L. Emerson Award is awarded in recognition of an outstanding research paper by an MGH Fellow in Psychology. This year’s recipient is Dr. Randi Melissa Schuster for her 2016 paper with co-authors Hoeppner, Evins and Gilman entitled “Inefficiencies in Learning Underlie Memory Deficits Among Early Onset Marijuana Users.” Dr. Schuster will present…MORE

Summary of the Marijuana and Cannabinoids Summit Now Available

Edin Evins at the Marijuana and Cannabinoids Summit , 2016

The summit which focused on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system, involved contributions by CAM doctors Eden Evins, Randi Schuster and Jodi Gilman. Videos of the proceedings, which took place in March of 2016 at the National Institutes of Health, were released earlier, but a written summary which makes it…MORE

Smoking Cessation Medications Do Not Appear to Increase Risk of Neuropsychiatric Side Effects

The Lancet

The smoking cessation medications varenicline and bupropion do not appear to increase the incidence of serious neuropsychiatric side effects compared to placebo, according to a study published in The Lancet in April, this paper provides details of the FDA-requested study that involved over 8,000 people. Read about it in the Lancet and ScienceDaily. Laurie Zawertailo comments…MORE

Smoking Cessation Benefits Persist in Spite of Weight Gain in Patients with Mental Illness

The weight gain that can result from quitting smoking does not eliminate the reduction in cardiovascular risks associated with smoking cessation among patients with serious mental illness, at least not during the first year. A report from a Massachusetts General Hospital (MGH)-based research team, published online in The Journal of Clinical Psychiatry  describes the results…MORE

Different Responses in the Brains of Young Marijuana Users

Young man smoking pot

A study by CAM researchers published in the journal Biological Psychiatry Cognitive Neuroscience and Neuroimaging finds that the brains of young adult marijuana users react differently to social exclusion than do those of non-users. Learn more in a press release from MGH and on the Science Explorer website.

Research on Pot and the Teen Brain

Research on Pot and the Teen Brain

A new CAM study targets young marijuana smokers, focusing on how drug abstinence impacts cognitive skills of teen subjects. An article in proto, MGH’s online magazine, looks at the study and others, and talks about how changing laws are creating a more accepting environment for a substance that might have more lasting effects than most…MORE

Videos of Proceedings of the Marijuana and Cannabinoids Summit Now Available

Marijuana and Cannabinoids: A Neuroscience Research Summit (March 22-23)

Dr. Evins spoke and Drs. Randi Schuster and Jodi Gilman presented their latest studies at the Neuroscience Research Summit, convened by the National Institutes of Health (NIH). The summit focused on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system. The goal of this summit was to ensure that evidence-based information…MORE